AlphaMark Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-31,391
| Closed | -$2.5M | – | 516 |
|
2019
Q3 | $2.5M | Sell |
31,391
-918
| -3% | -$73.2K | 1.09% | 39 |
|
2019
Q2 | $2.52M | Sell |
32,309
-1,361
| -4% | -$106K | 1.11% | 38 |
|
2019
Q1 | $3.95M | Sell |
33,670
-1,077
| -3% | -$126K | 1.67% | 17 |
|
2018
Q4 | $3.78M | Sell |
34,747
-2,737
| -7% | -$298K | 1.82% | 15 |
|
2018
Q3 | $4.79M | Sell |
37,484
-206
| -0.5% | -$26.3K | 1.93% | 11 |
|
2018
Q2 | $4.27M | Buy |
37,690
+834
| +2% | +$94.4K | 1.73% | 12 |
|
2018
Q1 | $4.14M | Buy |
36,856
+36,806
| +73,612% | +$4.14M | 1.77% | 14 |
|
2017
Q4 | $7K | Hold |
50
| – | – | ﹤0.01% | 388 |
|
2017
Q3 | $6K | Hold |
50
| – | – | ﹤0.01% | 395 |
|
2017
Q2 | $6K | Hold |
50
| – | – | ﹤0.01% | 405 |
|
2017
Q1 | $7K | Hold |
50
| – | – | ﹤0.01% | 373 |
|
2016
Q4 | $7K | Buy |
+50
| New | +$7K | ﹤0.01% | 350 |
|